{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:47:14Z","timestamp":1790174834567,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.tmaid.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T17:50:39Z","timestamp":1519926639000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure"],"prefix":"10.1016","volume":"24","author":[{"given":"Jacques-Robert","family":"Christen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Bourreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Demar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lightburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Couppi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Ginouv\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Pr\u00e9vot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Savini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"de Laval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pommier de Santi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Briolant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1473-3099(16)00003-7","article-title":"Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study 2013","volume":"16","author":"Karimkhani","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","article-title":"New world cutaneous leishmaniasis in travellers","volume":"6","author":"Schwartz","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.lpm.2013.03.010","article-title":"Epidemiology of autochthonous leishmaniasis in France","volume":"42","author":"Dedet","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.tmaid.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41182-017-0045-x","article-title":"Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP","volume":"45","author":"Simon","year":"2017","journal-title":"Trop Med Health"},{"key":"10.1016\/j.tmaid.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lpm.2010.09.023","article-title":"Therapy of leishmaniasis in France: consensus on proposed guidelines","volume":"40","author":"Buffet","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.tmaid.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3201\/eid1207.051466","article-title":"Leishmaniasis among gold miners, French Guiana","volume":"12","author":"Rotureau","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0398-7620(06)76717-7","article-title":"Outbreak of cutaneous leishmaniasis in military population coming back from French Guiana","volume":"54","author":"Berger","year":"2006","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.tmaid.2018.02.010_bib8","first-page":"297","article-title":"Epidemics of cutaneous leishmaniasis in military personnel working in French Guiana","volume":"60","author":"Banzet","year":"2000","journal-title":"Med Trop"},{"key":"10.1016\/j.tmaid.2018.02.010_bib9","first-page":"545","article-title":"Epidemiologic surveillance of cutaneous leishmaniasis in Guiana. Summary of military data collected over 10 years","volume":"62","author":"Lightburn","year":"2002","journal-title":"Med Trop"},{"key":"10.1016\/j.tmaid.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1645\/0022-3395(2001)087[1495:SFOIHD]2.0.CO;2","article-title":"Seasonal fluctuations of incubation, healing delays, and clinical presentation of cutaneous leishmaniasis in French Guiana","volume":"87","author":"Nacher","year":"2001","journal-title":"J Parasitol"},{"issue":"2","key":"10.1016\/j.tmaid.2018.02.010_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.diagmicrobio.2009.08.013","article-title":"Leishmania spp. identification by polymerase chain reaction-restriction fragment length polymorphism analysis and its applications in French Guiana","volume":"66","author":"Simon","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034983.2001.11813645","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis","volume":"86","author":"Neves","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiv355","article-title":"Presence of Leishmania RNA Virus 1 in Leishmania guyanensis increases the risk of first-line treatment failure and symptomatic relapse","volume":"213","author":"Bourreau","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/cid\/ciw742","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the american society of tropical medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1179\/000349802125002266","article-title":"Influence of meteorological parameters on the clinical presentation of cutaneous leishmaniasis in French Guiana and on the efficacy of pentamidine treatment of the disease","volume":"96","author":"Nacher","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/jiv354","article-title":"Association of the endobiont double-stranded RNA Virus LRV1 with treatment failure for human leishmaniasis caused by Leishmania braziliensis in Peru and Bolivia","volume":"213","author":"Adaui","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1086\/340526","article-title":"Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer","volume":"34","author":"Machado","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1086\/596508","article-title":"In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment","volume":"199","author":"Bourreau","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2004.06226.x","article-title":"Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana","volume":"151","author":"Couppi\u00e9","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"Llanos-Cuentas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib23","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.85.24.9572","article-title":"LR1: a candidate RNA virus of Leishmania","volume":"85","author":"Tarr","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmaid.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1126\/science.1199326","article-title":"Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis","volume":"331","author":"Ives","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tmaid.2018.02.010_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fcimb.2012.00099","article-title":"Leishmania RNA virus: when the host pays the toll","volume":"2","author":"Hartley","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib26","first-page":"21","article-title":"Comparison of Leishmania typing results obtained from 16 European clinical laboratories in 2014","author":"Van der Auwera","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jac\/dkg195","article-title":"Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis","volume":"51","author":"Delobel","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2018.02.010_bib28","first-page":"50","article-title":"Rhabdomyolysis induced by pentamidine (Pentacarinat) during treatment of cutaneous leishmaniasis: 2 cases","volume":"129","author":"Lieber-Mbomeyo","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/INF.0000000000000946","article-title":"Safe and effective prophylaxis with bimonthly intravenous pentamidine in the pediatric hematopoietic stem cell transplant population","volume":"35","author":"Levy","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2018.02.010_bib30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/INF.0b013e318292f560","article-title":"Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation","volume":"32","author":"DeMasi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","article-title":"Comparison between one and two injections of pentamidine isethionate, at 7 mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana","volume":"100","author":"Roussel","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib32","first-page":"35","article-title":"Management of American cutaneous leishmaniasis. Outcome apropos of 326 cases treated with high-dose pentamidine isethionate","volume":"63","author":"Lightburn","year":"2003","journal-title":"Med Trop"},{"key":"10.1016\/j.tmaid.2018.02.010_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-4632.2009.03883.x","article-title":"Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname","volume":"48","author":"van der Meide","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2018.02.010_bib34","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3201\/eid1309.061446","article-title":"Recurrent American cutaneous leishmaniasis","volume":"13","author":"Gangneux","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2018.02.010_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0035-9203(89)90373-8","article-title":"Isoenzyme characterization of 112 Leishmania isolates from French Guiana","volume":"83","author":"Desjeux","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2018.02.010_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4269\/ajtmh.15-0419","article-title":"Prevalence and distribution of Leishmania RNA virus 1 in Leishmania parasites from French Guiana","volume":"94","author":"Ginouv\u00e8s","year":"2016","journal-title":"Am J Trop Med Hyg"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893918300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893918300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:02:54Z","timestamp":1761487374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893918300401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":36,"alternative-id":["S1477893918300401"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2018.02.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739170781.793580943","asserted-by":"object"}]},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}